Gene · 9201
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Matrix stiffness induces Ca2+-DCLK1-PIP5K1A mechanotransduction as a context-specific amplifier in pancreatic cancer progression and chemotherapy resistance. | Exp Hematol Oncol | 2026 | 41692802 | PubTator, text mining | PubMed |
| Organoid-Immune Co-Cultures: A Next-Generation approach to disease modeling. | Mol Biol Rep | 2026 | 41636909 | PubTator, text mining | PubMed |
| DCLK1 drives malignant progression and chemoresistance of bladder cancer by deubiquitinating HDAC6. | Mol Cancer | 2026 | 41618382 | PubTator, text mining | PubMed |
| CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction. | Nat Commun | 2026 | 41571637 | PubTator, text mining | PubMed |
| Multi-center multi-omics integration predicts individualized prognosis in medullary thyroid carcinoma. | Nat Commun | 2026 | 41535264 | PubTator, text mining | PubMed |
| Targeting PLOD2 induces epithelioid differentiation and improves therapeutic response in sarcomatoid renal cell carcinoma. | J Adv Res | 2026 | 41109566 | PubTator, text mining | PubMed |
| Comparative study on the effects of glutamic acid and glutamine in promoting intestinal development in chicks through energy metabolism. | Anim Biosci | 2026 | 41035232 | PubTator, text mining | PubMed |
| Highlighting the Role of DCLK1 in Tumor Invasion and Potential for Therapeutic Intervention. | J Cancer Immunol (Wilmington) | 2025 | 41908079 | PubTator, text mining | PubMed |
| Patient-derived organoids in non-small cell lung cancer: advances in drug sensitivity testing. | Front Pharmacol | 2025 | 41560751 | PubTator, text mining | PubMed |
| Hepatocyte MLKL Drives Obesity-Driven Hepatocellular Carcinoma Progression via Mitochondrial Dysfunction Independent of Necroptosis in MASLD. | bioRxiv | 2025 | 41383755 | PubTator, text mining | PubMed |
| DLL Design with Wide Input Duty Cycle Range and Low Output Clock Duty Cycle Error. | Micromachines (Basel) | 2025 | 41302741 | PubTator, text mining | PubMed |
| A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth. | Sci Rep | 2025 | 41087459 | PubTator, text mining | PubMed |
| Tumor necrosis factor promotes doublecortin-like kinase 1 expression and cellular reprogramming in intestinal epithelial cells leading to neoplastic transformation. | Cell Commun Signal | 2025 | 41039610 | PubTator, text mining | PubMed |
| The Colonic Crypt: Cellular Dynamics and Signaling Pathways in Homeostasis and Cancer. | Cells | 2025 | 41002393 | PubTator, text mining | PubMed |
| Mucosal kinase activity and inflammatory profiles in inflammatory bowel disease, and in relation to tofacitinib response. | J Crohns Colitis | 2025 | 40986406 | PubTator, text mining | PubMed |
| Yes-associated protein 1 in cancer: bridging mechanical transduction and epigenetic regulation. | Cancer Biol Ther | 2025 | 40977060 | PubTator, text mining | PubMed |
| The histone acetylation-related gene signature predicts prognosis and immunotherapy response in stomach adenocarcinoma. | Front Oncol | 2025 | 40963862 | PubTator, text mining | PubMed |
| Stem Cells in Regenerative Medicine: A Journey from Adult Stem Cells to Induced Pluripotent Cells. | Int J Mol Sci | 2025 | 40943178 | PubTator, text mining | PubMed |
| Deciphering the unique autoregulatory mechanisms and substrate specificity of the understudied DCLK3 kinase linked to neurodegenerative diseases. | J Biol Chem | 2025 | 40902973 | PubTator, text mining | PubMed |
| The role of non-linear viscoelastic hydrogel mechanics in cell culture and transduction. | Mater Today Bio | 2025 | 40893357 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9201/papers?page=2